FDA Approved: HYDROXYCHLOROQUINE SULFATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for hydroxychloroquine sulfate submitted by Teva Pharmaceuticals USA, Inc. The action represents an FDA regulatory appro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Lupus Erythematosus
• Malaria
• Rheumatoid Arthritis
• Systemic Lupus Erythematosus

Drugs mentioned

• Hydroxychloroquine sulfate (Hydroxychloroquine sulfate)

Snippet

SUPPL AP for HYDROXYCHLOROQUINE SULFATE (HYDROXYCHLOROQUINE SULFATE)